Newron Pharmaceuticals SpA (NWRN)
Market Closed
15 Jun, 15:20
12. 10
CHF +0.04
+0.3317%
295.86M Market Cap
- P/E Ratio
- Div Yield
47,112 Volume
-0.44 Eps
12.06 CHF
Previous Close Want to track NWRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Newron Pharmaceuticals SpA (NWRN) Statistics
Valuation metrics
Market Cap 295.86M
Enterprise value 298.22M
Trailing P/E (ttm) -19.7
Forward P/E 19.65
PEG ratio 0.11
Price/Sales (ttm) 14.23
Price/Book (mrq) -23.48
Enterprise Value/Revenue 15.58
Enterprise Value/EBITDA -65.76
Overview
Shares outstanding 20.01M
Float 17.91M
Shares short -
% Held by insiders 0.13%
% Held by institutions 0.13%
Average volume (10 days) 58.89K
Average volume (90 days) 77.49K
Price summary
52-Week low 6.5
52-Week high 31.85
Beta 0.78
50-Day moving average 13.63
200-Day moving average 17.98
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.69%
Operating margin -0.25%
Operational effectiveness
Return on assets -0.33%
Return on equity 2.78%
Income Statement
Revenue (ttm) 17.49M
Revenue per share (ttm) 0.96
Quarterly revenue growth (yoy) -0.85%
Gross profit (ttm) 17.49M
EBITDA -4.28M
Net income to common (ttm) -12.11M
Diluted EPS (ttm) -0.66
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 26.41M
Total cash per share (mrq) 1.45
Total debt (mrq) 34.9M
Total Debt/Equity (mrq) -3.43
Current ratio (mrq) 0.76%
Book value per share (mrq) -0.56
Cash Flow
Cash flow statement 29.59M
Levered free cash flow (LFCF) 35.97M
